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The World Health Organization (WHO)’s priorities for the development of the classification 
of mental and behavioural disorders in the new version of the ICD-11 include increasing its 
clinical utility in global mental health settings (1) and improving the identification and diagnosis 
of mental disorders among children and adolescents (2).  
An issue that has been hotly debated in the area of childhood psychopathology is the 
assessment, diagnosis and treatment of children with severe irritability and anger (3-4). Although 
virtually all children display irritable and angry behaviors at times, some children exhibit them 
more frequently and more intensely, to the extent that they become an impairing form of 
emotional dysregulation. Recent findings indicate that these children with chronic and severe 
irritability/anger have not been adequately identified through existing classification systems, are 
at an increased risk for particular negative outcomes, and have not received appropriate 
treatment. To the extent that ICD-11 can help clarify the clinical picture of irritability/anger, 
children and families will benefit from more accurate diagnoses, more useful prognoses, and 
more effective interventions.  
This paper provides a brief overview of the issue, followed by several possible options and 
the current proposal for the classification of childhood irritability/anger in ICD-11. This proposal 
represents a markedly different – but we believe more scientifically justifiable – solution to the 
problems in this area than that selected for DSM-5 (5).  
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Clinical concerns related to severe irritability/anger in children 
 
Concern about misdiagnosis 
 
One of the major reasons why researchers and practitioners have been concerned about the 
classification of severe irritability/anger in children is that this phenomenon is widely believed to 
account for significant misdiagnosis of children as having bipolar disorder. This is particularly 
true in the U.S., where rates of bipolar disorder diagnoses in children increased by as much as 
4000% between 1994 and 2003 (6).  
The growing incidence of pediatric bipolar disorder appeared to be due to diagnostic errors 
or changing diagnostic conventions, since risk factors for the disorder had not changed and 
international data did not show a similar increase (7). The view that mania and hypomania could 
present as irritability among children appeared to underlie this changing diagnostic pattern (4,7).   
Notably, a large majority of the children diagnosed with bipolar disorder based on this 
interpretation of irritability would have also met the diagnostic requirements for oppositional 
defiant disorder (ODD) (4). Though generally grouped with conduct disorder and other disorders 
characterized by disruptive behavior, ODD is a disorder of emotional dysregulation (8), partially 
defined by affective symptoms of irritability and anger (5,9) and sharing significant comorbidity 
and continuity with mood and anxiety disorders (10-11).   
Thus, increasing rates of bipolar disorder diagnosis in children could reflect: a) diagnostic 
confusion regarding the presentation of bipolar disorder among children; and b) the presence of 
more severe symptoms of emotional dysregulation in children more properly considered as 
having ODD.  
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Concern about outcomes 
 
 Seeking to clarify the relationship between irritability and bipolar disorder, researchers at 
the U.S. National Institute of Mental Health began investigating “severe mood dysregulation” 
(SMD), a syndrome characterized by chronic abnormal levels of anger or sadness, hyperarousal 
evident in insomnia or agitation, and heightened verbal or physical reactivity (12). SMD and 
severe irritability/anger in childhood were found to predict anxiety and depressive disorders, but 
not bipolar disorders, in adolescence and adulthood (13-15).  
At the same time, researchers have examined the “irritability dimension” of ODD, which 
typically includes often losing one’s temper, being touchy, and being chronically or frequently 
angry, but not the hyperarousal symptoms of SMD (3). It has long been established that a 
significant proportion of children with ODD follow a developmental pathway leading to more 
serious antisocial behaviors characteristic of conduct disorder (16). However, children with these 
irritable/angry symptoms of ODD appear to follow a different course, with outcomes more 
commonly including later depression and anxiety (17-19), as well as peer victimization (20) and 
greater treatment resistance and functional impairment following treatment (21).  
Overall, severe irritability/anger appears to be a clinically significant feature and predictor of 
outcomes across development, from early childhood (22,23) through adulthood (15), with similar 
findings in girls and boys. Further, irritability/anger may have distinct genetic underpinnings 
from resistant behaviors and conduct problems (24). Clearly, this is an area deserving careful 
clinical attention.   
 
 
 
5 
 
Concern about selecting appropriate interventions  
 
During the period of increasing diagnostic rates of childhood bipolar disorder in the U.S., 
there was also an increasing tendency to use medications appropriate for adult bipolar disorder in 
an attempt to ameliorate high levels of anger and irritability in children (6,7), despite a paucity of 
clinical trials of these medications with child populations. However, children with severe 
irritability and anger are unlikely to exhibit manic or hypomanic episodes, either at the time of 
initial evaluation or in subsequent years (4), so that medications for bipolar disorder are probably 
not an appropriate treatment for them. On the other hand, there are several empirically based 
psychosocial interventions and medications that can be effective in treating childhood anger and 
reactive aggression (16,25). An improved diagnostic classification of childhood irritability/anger 
should help to facilitate more effective treatment. 
 
How to address these concerns?  
 
The developers of the DSM-5 (5) elected to address these concerns by adding a new 
diagnosis, disruptive mood dysregulation disorder (DMDD). Grouped among depressive 
disorders, DMDD is defined primarily by two features, present in multiple settings: a) frequent, 
severe temper outbursts, and b) persistent irritability evident every day for most of the day.  
The addition of this new disorder has been met with several negative reactions among the 
professional community (e.g., 26). These critics note that DMDD is based on limited research, is 
not sufficiently distinct from existing disorders (e.g., ODD), and may further contribute to 
increasing rates of mental disorders diagnoses and medication use among children. 
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Initially, the ICD-11 Working Group on the Classification of Mental and Behavioural 
Disorders in Children and Adolescents had recommended the inclusion of a modified version of 
DMDD (27) in the ICD-11. Reflecting the lack of consensus in the field, this proposal was later 
rejected by the ICD-11 Working Group on Mood and Anxiety Disorders, and the issue was taken 
up by an expanded group of experts appointed by the WHO. This article reflects the discussions 
and recommendations of that task group. 
 
Diagnostic options: a separate disorder or a specifier of an existing disorder 
 
A separate disorder 
 
 The rationale for introduction of DMDD in DSM-5 was developed largely out of the 
research on SMD (4). However, several limitations of this rationale should be noted.  
First, SMD research is still early in its development and comes from a small number of 
research groups, primarily in the U.S.. Additional independent and international research is 
needed, particularly to support validity of the diagnosis and its utility in a global classification 
system.   
Second, in the process of adapting SMD (the provisional research syndrome) into DMDD 
(the DSM-5 diagnosis), several significant changes were made, including removing hyperarousal 
(e.g., insomnia, agitation, distractibility, racing thoughts) from the essential criteria and 
removing low intelligence (IQ<80) from the exclusionary criteria (5,12). Consequently, the 
DMDD diagnosis had not been subjected to peer-reviewed research prior to the DSM-5 proposal.  
When DMDD was finally examined in field studies (28) and secondary analyses (29-31), 
evidence arose of limited reliability, a lack of psychiatric consensus, and very high rates of 
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overlap with other disorders. These findings are consistent with concerns raised in the 
professional community regarding DMDD (26) and suggest that the diagnosis is likely to be 
problematic in clinical settings. 
It is therefore unclear from the existing evidence that a new disorder category should be 
created. Although the DMDD diagnosis has been presented as a solution to the misdiagnosis and 
overmedication of children, its inclusion may in fact contribute to diagnostic confusion and 
create a new target, with a higher base rate, for drug development and trials. The task group did 
not consider that DMDD represents a meaningful response to the concerns described above 
related to the diagnosis, outcomes, and treatment of youth with severe irritability and anger. 
 
A specifier for ODD 
 
There is an alternative, empirically based solution that considers all of the available research 
on anger and irritability in children. As summarized above, numerous studies on SMD and ODD 
dimensions have found that children with severe irritability/anger are at a significant and specific 
risk for internalizing disorders and other poor psychosocial outcomes over time. The great 
majority of these children would already meet the diagnostic requirements for ODD and are not 
likely ever to develop bipolar disorder (3,4). Moreover, research evaluating different models of 
ODD dimensions (23,32) provides an empirical basis for how best to define this dimension 
within an existing diagnostic category. 
The task group has recommended that WHO not accept DMDD as a diagnostic category in 
ICD-11, but rather approach the issue in an alternative, more conservative and more 
scientifically justifiable way. Specifically, the group has proposed that ICD-11 include a 
specifier to indicate whether the presentation of ODD includes chronic irritability and anger or 
8 
 
not. We believe this option provides the most parsimonious basis for identifying and 
appropriately treating children with this maladaptive form of emotional dysregulation.  
Prior to the approval of the ICD-11 by the World Health Assembly, anticipated in 2017, 
proposals for ODD and related disorders will be subject to empirical evaluation and scrutiny by 
the global professional community through several avenues. These include a public review and 
comment process (see updates at http://apps.who.int/classifications/icd11/browse/l-m/en), and 
internet-based and clinic-based field studies conducted through WHO’s Global Clinical Practice 
Network (see http://www.globalclinicalpractice.net to register) and WHO’s network of 
international field study centers.  
The WHO will make final decisions about the classification of chronic irritability and anger 
in children and further refine the diagnostic guidelines for ODD and related disorders on the 
basis of the evidence generated through these processes. 
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